 HAUPPAUGE, N.Y., Dec. 17, 2020 GLOBE NEWSWIRE -- Chembio Diagnostics, Inc. Nasdaq: CEMI, a leading point-of-care diagnostic company focused on infectious diseases, today announced the appointment of David Acheson, M.D. to the Companys Board of Directors. 